Biden administration reverses Trump restrictions on fetal tissue research

Medical groups urged Biden to lift the ban shortly after he took officeFetal tissue research has been used in the development of numerous vaccines and treatments, including for Parkinson’s, HIV, and Covid-19.

The new guideline states that the ethics committee will no longer convene, but stresses that researchers must obtain consent from the fetal tissue donor, cannot pay for it, and must follow state laws that govern the practice.

HHS Secretary Xavier Becerra anticipated and defended the reversal of Trump policy during a hearing in the House of Representatives Thursday.

“We believe we need to do the research that is needed to make sure we innovate and bring all of these types of treatments and therapies to the American people,” he said.

Anti-abortion groups opposed the policy change, pledging to make it a topic in their campaign to reverse control of the House and Senate in the midterm elections.

“Abortion Democrats are pushing this deeply unpopular agenda at their own political risk,” said Susan B. Anthony List President Marjorie Dannenfelser.

Adam Cancryn contributed to this report.

Leave a Comment